Loading...
At this year's annual meeting of the American Society of Clinical Oncology (ASCO 2016), held June 3 to 7 in Chicago, investigators discussed the latest findings in cancer research. The editors of NEJM Journal Watch Oncology and Hematology were on hand to report highlights of the conference. Here, Associate Editor David H. Ilson, MD, PhD, reviews key presentations on new gastrointestinal cancer treatments. All meeting abstracts can be viewed in the ASCO meeting library).
Venook and colleagues assessed the impact of right- versus left-sided primary tumor site on both prognosis and the effectiveness of targeted therapy in patients with metastatic colorectal cancer in…